Anecova is a Swiss life science company focused on creating a more natural, physiological approach to Assisted Reproductive Technologies (ART). Our goals are to bring fertility treatment as close as possible to the circumstances of natural conception and to improve the overall quality of fertility care. The first Anecova product, AneVivo, aims to restore the fertilization and early development of the embryo to the natural environment of the maternal womb. This technology enables the embryos to start their life in close communication with the maternal environment.